Cancer immunotherapy efficacy and machine learning
Expert Review of Anticancer Therapy · 2024
DOI: 10.1080/14737140.2024.2311684 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Expert Review of Anticancer Therapy, 2024. Verfasst von Yuting Fang und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic…. Hauptthemen laut MEDLINE: Immunotherapy, Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: No funding.
Abstract (Originalsprache)
INTRODUCTION: Immunotherapy is one of the major breakthroughs in the treatment of cancer, and it has become a powerful clinical strategy, however, not all patients respond to immune checkpoint blockade and other immunotherapy strategies. Applying machine learning (ML) techniques to predict the efficacy of cancer immunotherapy is useful for clinical decision-making. AREAS COVERED: Applying ML including deep learning (DL) in radiomics, pathomics, tumor microenvironment (TME) and immune-related genes analysis to predict immunotherapy efficacy. The studies in this review were searched from PubMed and ClinicalTrials.gov (January 2023). EXPERT OPINION: An increasing number of studies indicate that ML has been applied to various aspects of oncology research, with the potential to provide more effective individualized immunotherapy strategies and enhance treatment decisions. With advances in ML technology, more efficient methods of predicting the efficacy of immunotherapy may become available in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences; Key Laborato…
- Postgraduate Training Base Alliance of Wenzhou Medical University (Zhejiang Cancer Hospital), Hangzhou, Zhejiang, China.
Förderung
- No funding
Zitieren
APA
Fang, Y., Chen, X., & Cao, C. (2024). Cancer immunotherapy efficacy and machine learning. Expert Review of Anticancer Therapy. https://doi.org/10.1080/14737140.2024.2311684
Vancouver
Fang Y, Chen X, Cao C. Cancer immunotherapy efficacy and machine learning. Expert Review of Anticancer Therapy. 2024. doi:10.1080/14737140.2024.2311684
BibTeX
@article{Fang2024,
author = {Fang, Yuting and Chen, Xiaozhong and Cao, Caineng},
title = {Cancer immunotherapy efficacy and machine learning},
journal = {Expert Review of Anticancer Therapy},
year = {2024},
doi = {10.1080/14737140.2024.2311684}
}
EUVIMED